Press Releases
February 23, 2021
AsclepiX Therapeutics partners with Notal Vision on Home OCT remote monitoring in DME and AMD clinical trials
January 12, 2021
Notal Vision Launches First U.S. Home OCT Longitudinal Study with Patient Self-operated Device
August 25, 2020
AI-based OCT analysis of AREDS2 10-Y follow-on study demonstrates superior performance over retina specialists
July 28, 2020
ForeseeHome AMD home monitoring real-world data analysis compares favorably to HOME study
June 17, 2020
Home OCT longitudinal home-based study with patient self-operated device has begun
Media enquiries? Reach out to our Media Contact